Search and Contain: Impact of an Integrated Genomic and Epidemiological Surveillance and Response Program for Control of Carbapenemase-producing Enterobacterales

被引:15
|
作者
Lane, Courtney R. [1 ,2 ]
Brett, Judith [3 ]
Schultz, Mark [1 ,2 ]
Gorrie, Claire L. [1 ,2 ]
Stevens, Kerrie [1 ]
Cameron, Donna R. M. [1 ,4 ]
St George, Siobhan [1 ]
van Diemen, Annaliese [4 ]
Easton, Marion [4 ]
Stuart, Rhonda L. [5 ]
Sait, Michelle [1 ]
Peleg, Anton Y. [6 ,7 ,8 ]
Stewardson, Andrew J. [6 ,7 ]
Cheng, Allen C. [6 ,7 ,9 ]
Spelman, Denis W. [6 ,7 ,10 ]
Waters, Mary Jo [11 ]
Ballard, Susan A. [1 ]
Sherry, Norelle L. [1 ,2 ,12 ]
Williamson, Deborah A. [1 ]
Romanes, Finn [4 ]
Sutton, Brett [4 ]
Kwong, Jason C. [2 ,12 ]
Seemann, Torsten [2 ]
da Silva, Anders Goncalves [1 ,2 ]
Stephens, Nicola [2 ,4 ,13 ]
Howden, Benjamin P. [1 ,2 ,12 ]
机构
[1] Peter Doherty Inst Infect & Immun, Microbiol Diagnost Unit, Univ Melbourne, Publ Hlth Lab, Melbourne, Vic, Australia
[2] Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Univ Melbourne, Melbourne, Vic, Australia
[3] Peter Doherty Inst Infect & Immun, VICNISS Healthcare Associated Infect Surveillance, Melbourne, Vic, Australia
[4] Victorian Govt, Dept Hlth & Human Serv, Melbourne, Vic, Australia
[5] Monash Hlth, Monash Med Ctr, Monash Infect Dis, Clayton, Vic, Australia
[6] Monash Univ, Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia
[7] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia
[8] Monash Univ, Monash Biomed Discovery Inst, Dept Microbiol, Infect & Immun Program, Clayton, Vic, Australia
[9] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[10] Alfred Hosp, Dept Microbiol, Melbourne, Vic, Australia
[11] St Vincents Hosp Melbourne, Dept Microbiol, Fitzroy, Vic, Australia
[12] Austin Hlth, Dept Infect Dis, Heidelberg, Vic, Australia
[13] Univ Tasmania, Hobart, Tas, Australia
基金
英国医学研究理事会;
关键词
antimicrobial resistance; public health surveillance; carbapenemase-producing Enterobacterales; infection control; genomics; KLEBSIELLA-PNEUMONIAE; DISSEMINATION; RESISTANCE; BACTERIA;
D O I
10.1093/cid/ciaa972
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Multiresistant organisms (MROs) pose a critical threat to public health. Population-based programs for control of MROs such as carbapenemase-producing Enterobacterales (CPE) have emerged and evaluation is needed. We assessed the feasibility and impact of a statewide CPE surveillance and response program deployed across Victoria, Australia (population 6.5 million). Methods. A prospective multimodal intervention including active screening, carrier isolation, centralized case investigation, and comparative pathogen genomics was implemented. We analyzed trends in CPE incidence and clinical presentation, risk factors, and local transmission over the program's first 3 years (2016-2018). Results. CPE case ascertainment increased over the study period to 1.42 cases/100 000 population, linked to increased screening without a concomitant rise in active clinical infections (0.45-0.60 infections/100 000 population, P = .640). KPC-2 infection decreased from 0.29 infections/100 000 population prior to intervention to 0.03 infections/100 000 population in 2018 (P = .003). Comprehensive case investigation identified instances of overseas community acquisition. Median time between isolate referral and genomic and epidemiological assessment for local transmission was 11 days (IQR, 9-14). Prospective surveillance identified numerous small transmission networks (median, 2; range, 1-19 cases), predominantly IMP and KPC, with median pairwise distance of 8 (IQR, 4-13) single nucleotide polymorphisms; low diversity between clusters of the same sequence type suggested genomic cluster definitions alone are insufficient for targeted response. Conclusions. We demonstrate the value of centralized CPE control programs to increase case ascertainment, resolve risk factors, and identify local transmission through prospective genomic and epidemiological surveillance; methodologies are transferable to low-prevalence settings and MROs globally.
引用
收藏
页码:E3912 / E3920
页数:9
相关论文
共 50 条
  • [21] Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance
    Zwaluw, K. van der
    Witteveen, S.
    Wielders, L.
    Santen, M. van
    Landman, F.
    Haan, A. de
    Schouls, L. M.
    Bosch, T.
    CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (10) : 1412.e7 - 1412.e12
  • [22] Evolving epidemiology of carbapenemase-producing Enterobacterales: one hospital's infection prevention and control response over nine years
    Foley, M.
    Duffy, F.
    Skally, M.
    McCormack, F.
    Finn, C.
    O'Connor, M.
    Cafferkey, J.
    Thomas, T.
    Burns, K.
    Fitzpatrick, F.
    O'Connell, K.
    Smyth, E. G.
    Humphreys, H.
    JOURNAL OF HOSPITAL INFECTION, 2021, 112 : 61 - 68
  • [23] Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study
    Kardas-Sloma, Lidia
    Fournier, Sandra
    Dupont, Jean-Claude
    Rochaix, Lise
    Birgand, Gabriel
    Zahar, Jean-Ralph
    Lescure, Francois-Xavier
    Kerneis, Solen
    Durand-Zaleski, Isabelle
    Lucet, Jean-Christophe
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2022, 11 (01)
  • [24] Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study
    Lidia Kardaś-Słoma
    Sandra Fournier
    Jean-Claude Dupont
    Lise Rochaix
    Gabriel Birgand
    Jean-Ralph Zahar
    François-Xavier Lescure
    Solen Kernéis
    Isabelle Durand-Zaleski
    Jean-Christophe Lucet
    Antimicrobial Resistance & Infection Control, 11
  • [25] Addressing the Rising Burden of Carbapenemase-Producing Enterobacterales in Liver Transplant Recipients: A Call for Enhanced Surveillance and Prevention Strategies
    Al-Maslamani, Muna A.
    Iqbal, Javed
    TRANSPLANT INFECTIOUS DISEASE, 2025,
  • [26] Dissemination of carbapenemase- producing Enterobacterales in Ireland from 2012 to 2017: a retrospective genomic surveillance study
    Hadjirin, Nazreen F.
    van Tonder, Andries J.
    Blane, Beth
    Lees, John A.
    Kumar, Narender
    Delappe, Niall
    Brennan, Wendy
    McGrath, Elaine
    Parkhill, Julian
    Cormican, Martin
    Peacock, Sharon J.
    Ludden, Catherine
    MICROBIAL GENOMICS, 2023, 9 (03):
  • [27] Simulation as a tool for promoting infection control measures during a carbapenemase-producing Enterobacterales outbreak: lessons learned
    Otu, A.
    Richards, A.
    Buckle, N.
    Blackmore, A.
    Adams, K.
    Wearmouth, D.
    JOURNAL OF HOSPITAL INFECTION, 2024, 153 : 1 - 2
  • [28] Epidemiology of carbapenemase-producing Enterobacterales in England, May 2015eMarch 2019 : national enhanced surveillance findings and approach
    Freeman, Rachel
    Ironmonger, Dean
    Hopkins, Katie L.
    Puleston, Richard
    Staves, Peter
    Hope, Russell
    Muller-Pebody, Berit
    Brown, Colin S.
    Hopkins, Susan
    Johnson, Alan P.
    Woodford, Neil
    Oliver, Isabel
    INFECTION PREVENTION IN PRACTICE, 2020, 2 (03)
  • [29] Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014
    Mataseje, Laura F.
    Abdesselam, Kahina
    Vachon, Julie
    Mitchel, Robyn
    Bryce, Elizabeth
    Roscoe, Diane
    Boyd, David A.
    Embree, Joanne
    Katz, Kevin
    Kibsey, Pamela
    Simor, Andrew E.
    Taylor, Geoffrey
    Turgeon, Nathalie
    Langley, Joanne
    Gravel, Denise
    Amaratunga, Kanchana
    Mulvey, Michael R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (11) : 6787 - 6794
  • [30] Epidemiological and bacteriological trends from 2013 to 2023 of carbapenemase-producing enterobacterales (CPE) in a French university hospital: A permanent risk of outbreak
    Robert, Manon
    Corvec, Stephane
    Andreo, Anais
    Le Gallou, Florence
    Marquot, Geraldine
    Mangeant, Reynald
    Bourigault, Celine
    Lepelletier, Didier
    INFECTIOUS DISEASES NOW, 2025, 55 (01):